Search Results - James, S. Jill

Jill James

Sandra Jill James is a retired American biochemist and autism researcher who studied metabolic autism biomarkers. She worked at Arkansas Children's Hospital Research Institute, where she was the director of the Metabolic Genomics Laboratory, as well as the University of Arkansas for Medical Sciences' department of pediatrics, where she began working in 2002. She was also a member of the Autism Speaks Treatment Advisory Board.

James' research focused on the role of epigenetics in autism, as well as the effectiveness of supplements as a treatment for autism and the potential existence of abnormal metabolism in autistic children. This research was previously funded by a 5-year grant from the National Institutes of Health entitled "Metabolic biomarkers of autism: predictive potential and genetic susceptibility", as well as by a grant from Autism Speaks.

James has falsely speculated that the thiomersal used as a preservative in some vaccines is potentially harmful to the human brain and that prophylactic supplements may protect against such harm preceding vaccination. Provided by Wikipedia
  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers by Neuhouser, Marian L. (Author) , Nijhout, H. Frederik (Author) , Gregory, Jesse F. (Author) , Reed, Michael C. (Author) , James, S. Jill (Author) , Liu, Amy (Author) , Shane, Barry (Author) , Ulrich, Cornelia (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:

Search Tools: